Dolby Laboratories, Inc.
DLB
$72.38
$0.931.30%
NYSE
| 06/27/2025 | 03/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -14.62% | 3.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.62% | 3.52% | |||
| Cost of Revenue | 22.78% | -12.11% | |||
| Gross Profit | -18.63% | 5.53% | |||
| SG&A Expenses | -0.98% | -2.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.22% | -5.26% | |||
| Operating Income | -57.94% | 31.58% | |||
| Income Before Tax | -53.83% | 39.74% | |||
| Income Tax Expenses | -67.98% | 55.85% | |||
| Earnings from Continuing Operations | -49.53% | 35.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -8.78% | -74.60% | |||
| Net Income | -49.81% | 35.34% | |||
| EBIT | -57.94% | 31.58% | |||
| EBITDA | -48.30% | 24.24% | |||
| EPS Basic | -49.59% | 34.34% | |||
| Normalized Basic EPS | -55.94% | 35.03% | |||
| EPS Diluted | -48.94% | 34.29% | |||
| Normalized Diluted EPS | -55.88% | 35.60% | |||
| Average Basic Shares Outstanding | -0.45% | 0.75% | |||
| Average Diluted Shares Outstanding | -0.59% | 0.33% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.98% | -0.25% | |||